fda bans semaglutide Shortage Ends: Compounded Versions Legal Battle Hims & Hers stock falls

Market leaders LLY and NVO are aggressively pursuing growth of their respective weight loss drug portfolios as the global obesity drug pipeline teems with potential disruptors

This highlights the need for further research to distinguish between the risk of developing an autoimmune phenotype and the risk of progressing to severe clinical manifestations like TED. While the research teams findings suggest a protective association between GLP-1 drug therapy and TED, the underlying biological pathways remain speculative

In a study on self-administered insulin injections, researchers concluded that bruising was often the result of patients pushing the pen into the skin

Clinical pharmacokinetics